Global Cardiac Safety Assessment Services Supply, Demand and Key Producers, 2024-2030

Global Cardiac Safety Assessment Services Supply, Demand and Key Producers, 2024-2030

Page: 162

Published Date: 08 May 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Cardiac safety assessment is an important, animal or animal tissue-based experimental procedure that must be considered before entering into clinical trials. In the past few years, some drugs that have been put into clinical use have had to be withdrawn from the market or their approval has been delayed because of their potential cardiotoxicity or causing severe cardiac arrhythmias.

The global Cardiac Safety Assessment Services market size is expected to reach $ 1358 million by 2030, rising at a market growth of 10.0% CAGR during the forecast period (2024-2030).

Drug-induced cardiotoxicity is one of the main reasons for new drugs to be discontinued or removed from the market. Therefore, cardiac safety assessment is a mandatory experimental procedure for various new drugs before entering clinical trials. At present, "hERG assay (hERG Assay)" (hERG assay is to evaluate the inhibitory effect of drugs on hERc current in stable expression cell lines) is considered to be the existing gold standard for preclinical cardiac safety assessment, and it is also the necessary information for new drug approval required by FDA.

Pharmaceutical companies invest in R&D to deliver high-quality and innovative products to the market, and current trends show that top pharmaceutical companies are increasing R&D efficiency through substantial R&D investments to achieve long-term ROI and through collaborative R&D efforts, which will help increase demand for preclinical and clinical services, including cardiac safety assessments.

This report studies the global Cardiac Safety Assessment Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cardiac Safety Assessment Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiac Safety Assessment Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cardiac Safety Assessment Services total market, 2019-2030, (USD Million)
Global Cardiac Safety Assessment Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cardiac Safety Assessment Services total market, key domestic companies, and share, (USD Million)
Global Cardiac Safety Assessment Services revenue by player, revenue and market share 2019-2024, (USD Million)
Global Cardiac Safety Assessment Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Cardiac Safety Assessment Services total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Cardiac Safety Assessment Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Laboratory Corporation of America Holdings, Metrion, Clario, Banook Group, Iqvia, Celerion, Certara, Biotrial, Medpace, Physiostim, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cardiac Safety Assessment Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cardiac Safety Assessment Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cardiac Safety Assessment Services Market, Segmentation by Type
Preclinical Cardiac Safety Assessment
Clinical Cardiac Safety Assessment

Global Cardiac Safety Assessment Services Market, Segmentation by Application:
Commissioned Research Institute
Pharmaceutical Company
Others

Companies Profiled:
Laboratory Corporation of America Holdings
Metrion
Clario
Banook Group
Iqvia
Celerion
Certara
Biotrial
Medpace
Physiostim
Richmond Pharmacology
Ncardia
Pharmaceutical Product Development Llc.
Reaction Biology
Eurofins Discovery
Altasciences
NEXEL
charles river
Scottish Institute of Electrophysiology
Ronovation Biotech
Elixir Clinical Research

Key Questions Answered
1. How big is the global Cardiac Safety Assessment Services market?
2. What is the demand of the global Cardiac Safety Assessment Services market?
3. What is the year over year growth of the global Cardiac Safety Assessment Services market?
4. What is the total value of the global Cardiac Safety Assessment Services market?
5. Who are the Major Players in the global Cardiac Safety Assessment Services market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Cardiac Safety Assessment Services Introduction
1.2 World Cardiac Safety Assessment Services Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Cardiac Safety Assessment Services Total Market by Region (by Headquarter Location)
1.3.1 World Cardiac Safety Assessment Services Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.3 China Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.4 Europe Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.5 Japan Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.6 South Korea Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.7 ASEAN Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.8 India Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiac Safety Assessment Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends

2 Demand Summary
2.1 World Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.2 World Cardiac Safety Assessment Services Consumption Value by Region
2.2.1 World Cardiac Safety Assessment Services Consumption Value by Region (2019-2024)
2.2.2 World Cardiac Safety Assessment Services Consumption Value Forecast by Region (2025-2030)
2.3 United States Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.4 China Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.5 Europe Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.6 Japan Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.7 South Korea Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.8 ASEAN Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.9 India Cardiac Safety Assessment Services Consumption Value (2019-2030)

3 World Cardiac Safety Assessment Services Companies Competitive Analysis
3.1 World Cardiac Safety Assessment Services Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cardiac Safety Assessment Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cardiac Safety Assessment Services in 2023
3.2.3 Global Concentration Ratios (CR8) for Cardiac Safety Assessment Services in 2023
3.3 Cardiac Safety Assessment Services Company Evaluation Quadrant
3.4 Cardiac Safety Assessment Services Market: Overall Company Footprint Analysis
3.4.1 Cardiac Safety Assessment Services Market: Region Footprint
3.4.2 Cardiac Safety Assessment Services Market: Company Product Type Footprint
3.4.3 Cardiac Safety Assessment Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Cardiac Safety Assessment Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cardiac Safety Assessment Services Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Cardiac Safety Assessment Services Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Cardiac Safety Assessment Services Consumption Value Comparison
4.2.1 United States VS China: Cardiac Safety Assessment Services Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Cardiac Safety Assessment Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Cardiac Safety Assessment Services Companies and Market Share, 2019-2024
4.3.1 United States Based Cardiac Safety Assessment Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cardiac Safety Assessment Services Revenue, (2019-2024)
4.4 China Based Companies Cardiac Safety Assessment Services Revenue and Market Share, 2019-2024
4.4.1 China Based Cardiac Safety Assessment Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cardiac Safety Assessment Services Revenue, (2019-2024)
4.5 Rest of World Based Cardiac Safety Assessment Services Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Cardiac Safety Assessment Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cardiac Safety Assessment Services Revenue (2019-2024)

5 Market Analysis by Type
5.1 World Cardiac Safety Assessment Services Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Preclinical Cardiac Safety Assessment
5.2.2 Clinical Cardiac Safety Assessment
5.3 Market Segment by Type
5.3.1 World Cardiac Safety Assessment Services Market Size by Type (2019-2024)
5.3.2 World Cardiac Safety Assessment Services Market Size by Type (2025-2030)
5.3.3 World Cardiac Safety Assessment Services Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
6.1 World Cardiac Safety Assessment Services Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Commissioned Research Institute
6.2.2 Pharmaceutical Company
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Cardiac Safety Assessment Services Market Size by Application (2019-2024)
6.3.2 World Cardiac Safety Assessment Services Market Size by Application (2025-2030)
6.3.3 World Cardiac Safety Assessment Services Market Size Market Share by Application (2019-2030)

7 Company Profiles
7.1 Laboratory Corporation of America Holdings
7.1.1 Laboratory Corporation of America Holdings Details
7.1.2 Laboratory Corporation of America Holdings Major Business
7.1.3 Laboratory Corporation of America Holdings Cardiac Safety Assessment Services Product and Services
7.1.4 Laboratory Corporation of America Holdings Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Laboratory Corporation of America Holdings Recent Developments/Updates
7.1.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
7.2 Metrion
7.2.1 Metrion Details
7.2.2 Metrion Major Business
7.2.3 Metrion Cardiac Safety Assessment Services Product and Services
7.2.4 Metrion Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Metrion Recent Developments/Updates
7.2.6 Metrion Competitive Strengths & Weaknesses
7.3 Clario
7.3.1 Clario Details
7.3.2 Clario Major Business
7.3.3 Clario Cardiac Safety Assessment Services Product and Services
7.3.4 Clario Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Clario Recent Developments/Updates
7.3.6 Clario Competitive Strengths & Weaknesses
7.4 Banook Group
7.4.1 Banook Group Details
7.4.2 Banook Group Major Business
7.4.3 Banook Group Cardiac Safety Assessment Services Product and Services
7.4.4 Banook Group Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Banook Group Recent Developments/Updates
7.4.6 Banook Group Competitive Strengths & Weaknesses
7.5 Iqvia
7.5.1 Iqvia Details
7.5.2 Iqvia Major Business
7.5.3 Iqvia Cardiac Safety Assessment Services Product and Services
7.5.4 Iqvia Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Iqvia Recent Developments/Updates
7.5.6 Iqvia Competitive Strengths & Weaknesses
7.6 Celerion
7.6.1 Celerion Details
7.6.2 Celerion Major Business
7.6.3 Celerion Cardiac Safety Assessment Services Product and Services
7.6.4 Celerion Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Celerion Recent Developments/Updates
7.6.6 Celerion Competitive Strengths & Weaknesses
7.7 Certara
7.7.1 Certara Details
7.7.2 Certara Major Business
7.7.3 Certara Cardiac Safety Assessment Services Product and Services
7.7.4 Certara Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Certara Recent Developments/Updates
7.7.6 Certara Competitive Strengths & Weaknesses
7.8 Biotrial
7.8.1 Biotrial Details
7.8.2 Biotrial Major Business
7.8.3 Biotrial Cardiac Safety Assessment Services Product and Services
7.8.4 Biotrial Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Biotrial Recent Developments/Updates
7.8.6 Biotrial Competitive Strengths & Weaknesses
7.9 Medpace
7.9.1 Medpace Details
7.9.2 Medpace Major Business
7.9.3 Medpace Cardiac Safety Assessment Services Product and Services
7.9.4 Medpace Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Medpace Recent Developments/Updates
7.9.6 Medpace Competitive Strengths & Weaknesses
7.10 Physiostim
7.10.1 Physiostim Details
7.10.2 Physiostim Major Business
7.10.3 Physiostim Cardiac Safety Assessment Services Product and Services
7.10.4 Physiostim Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Physiostim Recent Developments/Updates
7.10.6 Physiostim Competitive Strengths & Weaknesses
7.11 Richmond Pharmacology
7.11.1 Richmond Pharmacology Details
7.11.2 Richmond Pharmacology Major Business
7.11.3 Richmond Pharmacology Cardiac Safety Assessment Services Product and Services
7.11.4 Richmond Pharmacology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Richmond Pharmacology Recent Developments/Updates
7.11.6 Richmond Pharmacology Competitive Strengths & Weaknesses
7.12 Ncardia
7.12.1 Ncardia Details
7.12.2 Ncardia Major Business
7.12.3 Ncardia Cardiac Safety Assessment Services Product and Services
7.12.4 Ncardia Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Ncardia Recent Developments/Updates
7.12.6 Ncardia Competitive Strengths & Weaknesses
7.13 Pharmaceutical Product Development Llc.
7.13.1 Pharmaceutical Product Development Llc. Details
7.13.2 Pharmaceutical Product Development Llc. Major Business
7.13.3 Pharmaceutical Product Development Llc. Cardiac Safety Assessment Services Product and Services
7.13.4 Pharmaceutical Product Development Llc. Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Pharmaceutical Product Development Llc. Recent Developments/Updates
7.13.6 Pharmaceutical Product Development Llc. Competitive Strengths & Weaknesses
7.14 Reaction Biology
7.14.1 Reaction Biology Details
7.14.2 Reaction Biology Major Business
7.14.3 Reaction Biology Cardiac Safety Assessment Services Product and Services
7.14.4 Reaction Biology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Reaction Biology Recent Developments/Updates
7.14.6 Reaction Biology Competitive Strengths & Weaknesses
7.15 Eurofins Discovery
7.15.1 Eurofins Discovery Details
7.15.2 Eurofins Discovery Major Business
7.15.3 Eurofins Discovery Cardiac Safety Assessment Services Product and Services
7.15.4 Eurofins Discovery Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Eurofins Discovery Recent Developments/Updates
7.15.6 Eurofins Discovery Competitive Strengths & Weaknesses
7.16 Altasciences
7.16.1 Altasciences Details
7.16.2 Altasciences Major Business
7.16.3 Altasciences Cardiac Safety Assessment Services Product and Services
7.16.4 Altasciences Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Altasciences Recent Developments/Updates
7.16.6 Altasciences Competitive Strengths & Weaknesses
7.17 NEXEL
7.17.1 NEXEL Details
7.17.2 NEXEL Major Business
7.17.3 NEXEL Cardiac Safety Assessment Services Product and Services
7.17.4 NEXEL Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 NEXEL Recent Developments/Updates
7.17.6 NEXEL Competitive Strengths & Weaknesses
7.18 charles river
7.18.1 charles river Details
7.18.2 charles river Major Business
7.18.3 charles river Cardiac Safety Assessment Services Product and Services
7.18.4 charles river Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 charles river Recent Developments/Updates
7.18.6 charles river Competitive Strengths & Weaknesses
7.19 Scottish Institute of Electrophysiology
7.19.1 Scottish Institute of Electrophysiology Details
7.19.2 Scottish Institute of Electrophysiology Major Business
7.19.3 Scottish Institute of Electrophysiology Cardiac Safety Assessment Services Product and Services
7.19.4 Scottish Institute of Electrophysiology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Scottish Institute of Electrophysiology Recent Developments/Updates
7.19.6 Scottish Institute of Electrophysiology Competitive Strengths & Weaknesses
7.20 Ronovation Biotech
7.20.1 Ronovation Biotech Details
7.20.2 Ronovation Biotech Major Business
7.20.3 Ronovation Biotech Cardiac Safety Assessment Services Product and Services
7.20.4 Ronovation Biotech Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 Ronovation Biotech Recent Developments/Updates
7.20.6 Ronovation Biotech Competitive Strengths & Weaknesses
7.21 Elixir Clinical Research
7.21.1 Elixir Clinical Research Details
7.21.2 Elixir Clinical Research Major Business
7.21.3 Elixir Clinical Research Cardiac Safety Assessment Services Product and Services
7.21.4 Elixir Clinical Research Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.21.5 Elixir Clinical Research Recent Developments/Updates
7.21.6 Elixir Clinical Research Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Cardiac Safety Assessment Services Industry Chain
8.2 Cardiac Safety Assessment Services Upstream Analysis
8.3 Cardiac Safety Assessment Services Midstream Analysis
8.4 Cardiac Safety Assessment Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Cardiac Safety Assessment Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Cardiac Safety Assessment Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Cardiac Safety Assessment Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Cardiac Safety Assessment Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Cardiac Safety Assessment Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cardiac Safety Assessment Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Cardiac Safety Assessment Services Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Cardiac Safety Assessment Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Cardiac Safety Assessment Services Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Cardiac Safety Assessment Services Players in 2023
Table 12. World Cardiac Safety Assessment Services Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Cardiac Safety Assessment Services Company Evaluation Quadrant
Table 14. Head Office of Key Cardiac Safety Assessment Services Players
Table 15. Cardiac Safety Assessment Services Market: Company Product Type Footprint
Table 16. Cardiac Safety Assessment Services Market: Company Product Application Footprint
Table 17. Cardiac Safety Assessment Services Mergers & Acquisitions Activity
Table 18. United States VS China Cardiac Safety Assessment Services Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Cardiac Safety Assessment Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Cardiac Safety Assessment Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cardiac Safety Assessment Services Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Cardiac Safety Assessment Services Revenue Market Share (2019-2024)
Table 23. China Based Cardiac Safety Assessment Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cardiac Safety Assessment Services Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Cardiac Safety Assessment Services Revenue Market Share (2019-2024)
Table 26. Rest of World Based Cardiac Safety Assessment Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cardiac Safety Assessment Services Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Cardiac Safety Assessment Services Revenue Market Share (2019-2024)
Table 29. World Cardiac Safety Assessment Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Cardiac Safety Assessment Services Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Cardiac Safety Assessment Services Market Size by Type (2025-2030) & (USD Million)
Table 32. World Cardiac Safety Assessment Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Cardiac Safety Assessment Services Market Size by Application (2019-2024) & (USD Million)
Table 34. World Cardiac Safety Assessment Services Market Size by Application (2025-2030) & (USD Million)
Table 35. Laboratory Corporation of America Holdings Basic Information, Manufacturing Base and Competitors
Table 36. Laboratory Corporation of America Holdings Major Business
Table 37. Laboratory Corporation of America Holdings Cardiac Safety Assessment Services Product and Services
Table 38. Laboratory Corporation of America Holdings Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Laboratory Corporation of America Holdings Recent Developments/Updates
Table 40. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
Table 41. Metrion Basic Information, Manufacturing Base and Competitors
Table 42. Metrion Major Business
Table 43. Metrion Cardiac Safety Assessment Services Product and Services
Table 44. Metrion Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Metrion Recent Developments/Updates
Table 46. Metrion Competitive Strengths & Weaknesses
Table 47. Clario Basic Information, Manufacturing Base and Competitors
Table 48. Clario Major Business
Table 49. Clario Cardiac Safety Assessment Services Product and Services
Table 50. Clario Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Clario Recent Developments/Updates
Table 52. Clario Competitive Strengths & Weaknesses
Table 53. Banook Group Basic Information, Manufacturing Base and Competitors
Table 54. Banook Group Major Business
Table 55. Banook Group Cardiac Safety Assessment Services Product and Services
Table 56. Banook Group Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Banook Group Recent Developments/Updates
Table 58. Banook Group Competitive Strengths & Weaknesses
Table 59. Iqvia Basic Information, Manufacturing Base and Competitors
Table 60. Iqvia Major Business
Table 61. Iqvia Cardiac Safety Assessment Services Product and Services
Table 62. Iqvia Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Iqvia Recent Developments/Updates
Table 64. Iqvia Competitive Strengths & Weaknesses
Table 65. Celerion Basic Information, Manufacturing Base and Competitors
Table 66. Celerion Major Business
Table 67. Celerion Cardiac Safety Assessment Services Product and Services
Table 68. Celerion Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Celerion Recent Developments/Updates
Table 70. Celerion Competitive Strengths & Weaknesses
Table 71. Certara Basic Information, Manufacturing Base and Competitors
Table 72. Certara Major Business
Table 73. Certara Cardiac Safety Assessment Services Product and Services
Table 74. Certara Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Certara Recent Developments/Updates
Table 76. Certara Competitive Strengths & Weaknesses
Table 77. Biotrial Basic Information, Manufacturing Base and Competitors
Table 78. Biotrial Major Business
Table 79. Biotrial Cardiac Safety Assessment Services Product and Services
Table 80. Biotrial Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Biotrial Recent Developments/Updates
Table 82. Biotrial Competitive Strengths & Weaknesses
Table 83. Medpace Basic Information, Manufacturing Base and Competitors
Table 84. Medpace Major Business
Table 85. Medpace Cardiac Safety Assessment Services Product and Services
Table 86. Medpace Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Medpace Recent Developments/Updates
Table 88. Medpace Competitive Strengths & Weaknesses
Table 89. Physiostim Basic Information, Manufacturing Base and Competitors
Table 90. Physiostim Major Business
Table 91. Physiostim Cardiac Safety Assessment Services Product and Services
Table 92. Physiostim Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Physiostim Recent Developments/Updates
Table 94. Physiostim Competitive Strengths & Weaknesses
Table 95. Richmond Pharmacology Basic Information, Manufacturing Base and Competitors
Table 96. Richmond Pharmacology Major Business
Table 97. Richmond Pharmacology Cardiac Safety Assessment Services Product and Services
Table 98. Richmond Pharmacology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Richmond Pharmacology Recent Developments/Updates
Table 100. Richmond Pharmacology Competitive Strengths & Weaknesses
Table 101. Ncardia Basic Information, Manufacturing Base and Competitors
Table 102. Ncardia Major Business
Table 103. Ncardia Cardiac Safety Assessment Services Product and Services
Table 104. Ncardia Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Ncardia Recent Developments/Updates
Table 106. Ncardia Competitive Strengths & Weaknesses
Table 107. Pharmaceutical Product Development Llc. Basic Information, Manufacturing Base and Competitors
Table 108. Pharmaceutical Product Development Llc. Major Business
Table 109. Pharmaceutical Product Development Llc. Cardiac Safety Assessment Services Product and Services
Table 110. Pharmaceutical Product Development Llc. Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Pharmaceutical Product Development Llc. Recent Developments/Updates
Table 112. Pharmaceutical Product Development Llc. Competitive Strengths & Weaknesses
Table 113. Reaction Biology Basic Information, Manufacturing Base and Competitors
Table 114. Reaction Biology Major Business
Table 115. Reaction Biology Cardiac Safety Assessment Services Product and Services
Table 116. Reaction Biology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Reaction Biology Recent Developments/Updates
Table 118. Reaction Biology Competitive Strengths & Weaknesses
Table 119. Eurofins Discovery Basic Information, Manufacturing Base and Competitors
Table 120. Eurofins Discovery Major Business
Table 121. Eurofins Discovery Cardiac Safety Assessment Services Product and Services
Table 122. Eurofins Discovery Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Eurofins Discovery Recent Developments/Updates
Table 124. Eurofins Discovery Competitive Strengths & Weaknesses
Table 125. Altasciences Basic Information, Manufacturing Base and Competitors
Table 126. Altasciences Major Business
Table 127. Altasciences Cardiac Safety Assessment Services Product and Services
Table 128. Altasciences Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Altasciences Recent Developments/Updates
Table 130. Altasciences Competitive Strengths & Weaknesses
Table 131. NEXEL Basic Information, Manufacturing Base and Competitors
Table 132. NEXEL Major Business
Table 133. NEXEL Cardiac Safety Assessment Services Product and Services
Table 134. NEXEL Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. NEXEL Recent Developments/Updates
Table 136. NEXEL Competitive Strengths & Weaknesses
Table 137. charles river Basic Information, Manufacturing Base and Competitors
Table 138. charles river Major Business
Table 139. charles river Cardiac Safety Assessment Services Product and Services
Table 140. charles river Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. charles river Recent Developments/Updates
Table 142. charles river Competitive Strengths & Weaknesses
Table 143. Scottish Institute of Electrophysiology Basic Information, Manufacturing Base and Competitors
Table 144. Scottish Institute of Electrophysiology Major Business
Table 145. Scottish Institute of Electrophysiology Cardiac Safety Assessment Services Product and Services
Table 146. Scottish Institute of Electrophysiology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Scottish Institute of Electrophysiology Recent Developments/Updates
Table 148. Scottish Institute of Electrophysiology Competitive Strengths & Weaknesses
Table 149. Ronovation Biotech Basic Information, Manufacturing Base and Competitors
Table 150. Ronovation Biotech Major Business
Table 151. Ronovation Biotech Cardiac Safety Assessment Services Product and Services
Table 152. Ronovation Biotech Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 153. Ronovation Biotech Recent Developments/Updates
Table 154. Ronovation Biotech Competitive Strengths & Weaknesses
Table 155. Elixir Clinical Research Basic Information, Manufacturing Base and Competitors
Table 156. Elixir Clinical Research Major Business
Table 157. Elixir Clinical Research Cardiac Safety Assessment Services Product and Services
Table 158. Elixir Clinical Research Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 159. Elixir Clinical Research Recent Developments/Updates
Table 160. Elixir Clinical Research Competitive Strengths & Weaknesses
Table 161. Global Key Players of Cardiac Safety Assessment Services Upstream (Raw Materials)
Table 162. Global Cardiac Safety Assessment Services Typical Customers


List of Figures
Figure 1. Cardiac Safety Assessment Services Picture
Figure 2. World Cardiac Safety Assessment Services Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Cardiac Safety Assessment Services Total Revenue (2019-2030) & (USD Million)
Figure 4. World Cardiac Safety Assessment Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Cardiac Safety Assessment Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 13. Cardiac Safety Assessment Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 16. World Cardiac Safety Assessment Services Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 18. China Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 23. India Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Cardiac Safety Assessment Services by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cardiac Safety Assessment Services Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cardiac Safety Assessment Services Markets in 2023
Figure 27. United States VS China: Cardiac Safety Assessment Services Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Cardiac Safety Assessment Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Cardiac Safety Assessment Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Cardiac Safety Assessment Services Market Size Market Share by Type in 2023
Figure 31. Preclinical Cardiac Safety Assessment
Figure 32. Clinical Cardiac Safety Assessment
Figure 33. World Cardiac Safety Assessment Services Market Size Market Share by Type (2019-2030)
Figure 34. World Cardiac Safety Assessment Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Cardiac Safety Assessment Services Market Size Market Share by Application in 2023
Figure 36. Commissioned Research Institute
Figure 37. Pharmaceutical Company
Figure 38. Others
Figure 39. World Cardiac Safety Assessment Services Market Size Market Share by Application (2019-2030)
Figure 40. Cardiac Safety Assessment Services Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Laboratory Corporation of America Holdings
Metrion
Clario
Banook Group
Iqvia
Celerion
Certara
Biotrial
Medpace
Physiostim
Richmond Pharmacology
Ncardia
Pharmaceutical Product Development Llc.
Reaction Biology
Eurofins Discovery
Altasciences
NEXEL
charles river
Scottish Institute of Electrophysiology
Ronovation Biotech
Elixir Clinical Research
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Cardiac Safety Assessment Services Supply, Demand and Key Producers, 2024-2030

Global Cardiac Safety Assessment Services Supply, Demand and Key Producers, 2024-2030

Page: 162

Published Date: 08 May 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Cardiac safety assessment is an important, animal or animal tissue-based experimental procedure that must be considered before entering into clinical trials. In the past few years, some drugs that have been put into clinical use have had to be withdrawn from the market or their approval has been delayed because of their potential cardiotoxicity or causing severe cardiac arrhythmias.

The global Cardiac Safety Assessment Services market size is expected to reach $ 1358 million by 2030, rising at a market growth of 10.0% CAGR during the forecast period (2024-2030).

Drug-induced cardiotoxicity is one of the main reasons for new drugs to be discontinued or removed from the market. Therefore, cardiac safety assessment is a mandatory experimental procedure for various new drugs before entering clinical trials. At present, "hERG assay (hERG Assay)" (hERG assay is to evaluate the inhibitory effect of drugs on hERc current in stable expression cell lines) is considered to be the existing gold standard for preclinical cardiac safety assessment, and it is also the necessary information for new drug approval required by FDA.

Pharmaceutical companies invest in R&D to deliver high-quality and innovative products to the market, and current trends show that top pharmaceutical companies are increasing R&D efficiency through substantial R&D investments to achieve long-term ROI and through collaborative R&D efforts, which will help increase demand for preclinical and clinical services, including cardiac safety assessments.

This report studies the global Cardiac Safety Assessment Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cardiac Safety Assessment Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiac Safety Assessment Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cardiac Safety Assessment Services total market, 2019-2030, (USD Million)
Global Cardiac Safety Assessment Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cardiac Safety Assessment Services total market, key domestic companies, and share, (USD Million)
Global Cardiac Safety Assessment Services revenue by player, revenue and market share 2019-2024, (USD Million)
Global Cardiac Safety Assessment Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Cardiac Safety Assessment Services total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Cardiac Safety Assessment Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Laboratory Corporation of America Holdings, Metrion, Clario, Banook Group, Iqvia, Celerion, Certara, Biotrial, Medpace, Physiostim, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cardiac Safety Assessment Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cardiac Safety Assessment Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cardiac Safety Assessment Services Market, Segmentation by Type
Preclinical Cardiac Safety Assessment
Clinical Cardiac Safety Assessment

Global Cardiac Safety Assessment Services Market, Segmentation by Application:
Commissioned Research Institute
Pharmaceutical Company
Others

Companies Profiled:
Laboratory Corporation of America Holdings
Metrion
Clario
Banook Group
Iqvia
Celerion
Certara
Biotrial
Medpace
Physiostim
Richmond Pharmacology
Ncardia
Pharmaceutical Product Development Llc.
Reaction Biology
Eurofins Discovery
Altasciences
NEXEL
charles river
Scottish Institute of Electrophysiology
Ronovation Biotech
Elixir Clinical Research

Key Questions Answered
1. How big is the global Cardiac Safety Assessment Services market?
2. What is the demand of the global Cardiac Safety Assessment Services market?
3. What is the year over year growth of the global Cardiac Safety Assessment Services market?
4. What is the total value of the global Cardiac Safety Assessment Services market?
5. Who are the Major Players in the global Cardiac Safety Assessment Services market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Cardiac Safety Assessment Services Introduction
1.2 World Cardiac Safety Assessment Services Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Cardiac Safety Assessment Services Total Market by Region (by Headquarter Location)
1.3.1 World Cardiac Safety Assessment Services Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.3 China Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.4 Europe Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.5 Japan Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.6 South Korea Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.7 ASEAN Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.3.8 India Based Company Cardiac Safety Assessment Services Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiac Safety Assessment Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends

2 Demand Summary
2.1 World Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.2 World Cardiac Safety Assessment Services Consumption Value by Region
2.2.1 World Cardiac Safety Assessment Services Consumption Value by Region (2019-2024)
2.2.2 World Cardiac Safety Assessment Services Consumption Value Forecast by Region (2025-2030)
2.3 United States Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.4 China Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.5 Europe Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.6 Japan Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.7 South Korea Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.8 ASEAN Cardiac Safety Assessment Services Consumption Value (2019-2030)
2.9 India Cardiac Safety Assessment Services Consumption Value (2019-2030)

3 World Cardiac Safety Assessment Services Companies Competitive Analysis
3.1 World Cardiac Safety Assessment Services Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cardiac Safety Assessment Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cardiac Safety Assessment Services in 2023
3.2.3 Global Concentration Ratios (CR8) for Cardiac Safety Assessment Services in 2023
3.3 Cardiac Safety Assessment Services Company Evaluation Quadrant
3.4 Cardiac Safety Assessment Services Market: Overall Company Footprint Analysis
3.4.1 Cardiac Safety Assessment Services Market: Region Footprint
3.4.2 Cardiac Safety Assessment Services Market: Company Product Type Footprint
3.4.3 Cardiac Safety Assessment Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Cardiac Safety Assessment Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cardiac Safety Assessment Services Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Cardiac Safety Assessment Services Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Cardiac Safety Assessment Services Consumption Value Comparison
4.2.1 United States VS China: Cardiac Safety Assessment Services Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Cardiac Safety Assessment Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Cardiac Safety Assessment Services Companies and Market Share, 2019-2024
4.3.1 United States Based Cardiac Safety Assessment Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cardiac Safety Assessment Services Revenue, (2019-2024)
4.4 China Based Companies Cardiac Safety Assessment Services Revenue and Market Share, 2019-2024
4.4.1 China Based Cardiac Safety Assessment Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cardiac Safety Assessment Services Revenue, (2019-2024)
4.5 Rest of World Based Cardiac Safety Assessment Services Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Cardiac Safety Assessment Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cardiac Safety Assessment Services Revenue (2019-2024)

5 Market Analysis by Type
5.1 World Cardiac Safety Assessment Services Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Preclinical Cardiac Safety Assessment
5.2.2 Clinical Cardiac Safety Assessment
5.3 Market Segment by Type
5.3.1 World Cardiac Safety Assessment Services Market Size by Type (2019-2024)
5.3.2 World Cardiac Safety Assessment Services Market Size by Type (2025-2030)
5.3.3 World Cardiac Safety Assessment Services Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
6.1 World Cardiac Safety Assessment Services Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Commissioned Research Institute
6.2.2 Pharmaceutical Company
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Cardiac Safety Assessment Services Market Size by Application (2019-2024)
6.3.2 World Cardiac Safety Assessment Services Market Size by Application (2025-2030)
6.3.3 World Cardiac Safety Assessment Services Market Size Market Share by Application (2019-2030)

7 Company Profiles
7.1 Laboratory Corporation of America Holdings
7.1.1 Laboratory Corporation of America Holdings Details
7.1.2 Laboratory Corporation of America Holdings Major Business
7.1.3 Laboratory Corporation of America Holdings Cardiac Safety Assessment Services Product and Services
7.1.4 Laboratory Corporation of America Holdings Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Laboratory Corporation of America Holdings Recent Developments/Updates
7.1.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
7.2 Metrion
7.2.1 Metrion Details
7.2.2 Metrion Major Business
7.2.3 Metrion Cardiac Safety Assessment Services Product and Services
7.2.4 Metrion Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Metrion Recent Developments/Updates
7.2.6 Metrion Competitive Strengths & Weaknesses
7.3 Clario
7.3.1 Clario Details
7.3.2 Clario Major Business
7.3.3 Clario Cardiac Safety Assessment Services Product and Services
7.3.4 Clario Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Clario Recent Developments/Updates
7.3.6 Clario Competitive Strengths & Weaknesses
7.4 Banook Group
7.4.1 Banook Group Details
7.4.2 Banook Group Major Business
7.4.3 Banook Group Cardiac Safety Assessment Services Product and Services
7.4.4 Banook Group Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Banook Group Recent Developments/Updates
7.4.6 Banook Group Competitive Strengths & Weaknesses
7.5 Iqvia
7.5.1 Iqvia Details
7.5.2 Iqvia Major Business
7.5.3 Iqvia Cardiac Safety Assessment Services Product and Services
7.5.4 Iqvia Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Iqvia Recent Developments/Updates
7.5.6 Iqvia Competitive Strengths & Weaknesses
7.6 Celerion
7.6.1 Celerion Details
7.6.2 Celerion Major Business
7.6.3 Celerion Cardiac Safety Assessment Services Product and Services
7.6.4 Celerion Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Celerion Recent Developments/Updates
7.6.6 Celerion Competitive Strengths & Weaknesses
7.7 Certara
7.7.1 Certara Details
7.7.2 Certara Major Business
7.7.3 Certara Cardiac Safety Assessment Services Product and Services
7.7.4 Certara Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Certara Recent Developments/Updates
7.7.6 Certara Competitive Strengths & Weaknesses
7.8 Biotrial
7.8.1 Biotrial Details
7.8.2 Biotrial Major Business
7.8.3 Biotrial Cardiac Safety Assessment Services Product and Services
7.8.4 Biotrial Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Biotrial Recent Developments/Updates
7.8.6 Biotrial Competitive Strengths & Weaknesses
7.9 Medpace
7.9.1 Medpace Details
7.9.2 Medpace Major Business
7.9.3 Medpace Cardiac Safety Assessment Services Product and Services
7.9.4 Medpace Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Medpace Recent Developments/Updates
7.9.6 Medpace Competitive Strengths & Weaknesses
7.10 Physiostim
7.10.1 Physiostim Details
7.10.2 Physiostim Major Business
7.10.3 Physiostim Cardiac Safety Assessment Services Product and Services
7.10.4 Physiostim Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Physiostim Recent Developments/Updates
7.10.6 Physiostim Competitive Strengths & Weaknesses
7.11 Richmond Pharmacology
7.11.1 Richmond Pharmacology Details
7.11.2 Richmond Pharmacology Major Business
7.11.3 Richmond Pharmacology Cardiac Safety Assessment Services Product and Services
7.11.4 Richmond Pharmacology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Richmond Pharmacology Recent Developments/Updates
7.11.6 Richmond Pharmacology Competitive Strengths & Weaknesses
7.12 Ncardia
7.12.1 Ncardia Details
7.12.2 Ncardia Major Business
7.12.3 Ncardia Cardiac Safety Assessment Services Product and Services
7.12.4 Ncardia Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Ncardia Recent Developments/Updates
7.12.6 Ncardia Competitive Strengths & Weaknesses
7.13 Pharmaceutical Product Development Llc.
7.13.1 Pharmaceutical Product Development Llc. Details
7.13.2 Pharmaceutical Product Development Llc. Major Business
7.13.3 Pharmaceutical Product Development Llc. Cardiac Safety Assessment Services Product and Services
7.13.4 Pharmaceutical Product Development Llc. Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Pharmaceutical Product Development Llc. Recent Developments/Updates
7.13.6 Pharmaceutical Product Development Llc. Competitive Strengths & Weaknesses
7.14 Reaction Biology
7.14.1 Reaction Biology Details
7.14.2 Reaction Biology Major Business
7.14.3 Reaction Biology Cardiac Safety Assessment Services Product and Services
7.14.4 Reaction Biology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Reaction Biology Recent Developments/Updates
7.14.6 Reaction Biology Competitive Strengths & Weaknesses
7.15 Eurofins Discovery
7.15.1 Eurofins Discovery Details
7.15.2 Eurofins Discovery Major Business
7.15.3 Eurofins Discovery Cardiac Safety Assessment Services Product and Services
7.15.4 Eurofins Discovery Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Eurofins Discovery Recent Developments/Updates
7.15.6 Eurofins Discovery Competitive Strengths & Weaknesses
7.16 Altasciences
7.16.1 Altasciences Details
7.16.2 Altasciences Major Business
7.16.3 Altasciences Cardiac Safety Assessment Services Product and Services
7.16.4 Altasciences Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Altasciences Recent Developments/Updates
7.16.6 Altasciences Competitive Strengths & Weaknesses
7.17 NEXEL
7.17.1 NEXEL Details
7.17.2 NEXEL Major Business
7.17.3 NEXEL Cardiac Safety Assessment Services Product and Services
7.17.4 NEXEL Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 NEXEL Recent Developments/Updates
7.17.6 NEXEL Competitive Strengths & Weaknesses
7.18 charles river
7.18.1 charles river Details
7.18.2 charles river Major Business
7.18.3 charles river Cardiac Safety Assessment Services Product and Services
7.18.4 charles river Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 charles river Recent Developments/Updates
7.18.6 charles river Competitive Strengths & Weaknesses
7.19 Scottish Institute of Electrophysiology
7.19.1 Scottish Institute of Electrophysiology Details
7.19.2 Scottish Institute of Electrophysiology Major Business
7.19.3 Scottish Institute of Electrophysiology Cardiac Safety Assessment Services Product and Services
7.19.4 Scottish Institute of Electrophysiology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Scottish Institute of Electrophysiology Recent Developments/Updates
7.19.6 Scottish Institute of Electrophysiology Competitive Strengths & Weaknesses
7.20 Ronovation Biotech
7.20.1 Ronovation Biotech Details
7.20.2 Ronovation Biotech Major Business
7.20.3 Ronovation Biotech Cardiac Safety Assessment Services Product and Services
7.20.4 Ronovation Biotech Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 Ronovation Biotech Recent Developments/Updates
7.20.6 Ronovation Biotech Competitive Strengths & Weaknesses
7.21 Elixir Clinical Research
7.21.1 Elixir Clinical Research Details
7.21.2 Elixir Clinical Research Major Business
7.21.3 Elixir Clinical Research Cardiac Safety Assessment Services Product and Services
7.21.4 Elixir Clinical Research Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024)
7.21.5 Elixir Clinical Research Recent Developments/Updates
7.21.6 Elixir Clinical Research Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Cardiac Safety Assessment Services Industry Chain
8.2 Cardiac Safety Assessment Services Upstream Analysis
8.3 Cardiac Safety Assessment Services Midstream Analysis
8.4 Cardiac Safety Assessment Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Cardiac Safety Assessment Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Cardiac Safety Assessment Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Cardiac Safety Assessment Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Cardiac Safety Assessment Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Cardiac Safety Assessment Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cardiac Safety Assessment Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Cardiac Safety Assessment Services Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Cardiac Safety Assessment Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Cardiac Safety Assessment Services Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Cardiac Safety Assessment Services Players in 2023
Table 12. World Cardiac Safety Assessment Services Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Cardiac Safety Assessment Services Company Evaluation Quadrant
Table 14. Head Office of Key Cardiac Safety Assessment Services Players
Table 15. Cardiac Safety Assessment Services Market: Company Product Type Footprint
Table 16. Cardiac Safety Assessment Services Market: Company Product Application Footprint
Table 17. Cardiac Safety Assessment Services Mergers & Acquisitions Activity
Table 18. United States VS China Cardiac Safety Assessment Services Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Cardiac Safety Assessment Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Cardiac Safety Assessment Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cardiac Safety Assessment Services Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Cardiac Safety Assessment Services Revenue Market Share (2019-2024)
Table 23. China Based Cardiac Safety Assessment Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cardiac Safety Assessment Services Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Cardiac Safety Assessment Services Revenue Market Share (2019-2024)
Table 26. Rest of World Based Cardiac Safety Assessment Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cardiac Safety Assessment Services Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Cardiac Safety Assessment Services Revenue Market Share (2019-2024)
Table 29. World Cardiac Safety Assessment Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Cardiac Safety Assessment Services Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Cardiac Safety Assessment Services Market Size by Type (2025-2030) & (USD Million)
Table 32. World Cardiac Safety Assessment Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Cardiac Safety Assessment Services Market Size by Application (2019-2024) & (USD Million)
Table 34. World Cardiac Safety Assessment Services Market Size by Application (2025-2030) & (USD Million)
Table 35. Laboratory Corporation of America Holdings Basic Information, Manufacturing Base and Competitors
Table 36. Laboratory Corporation of America Holdings Major Business
Table 37. Laboratory Corporation of America Holdings Cardiac Safety Assessment Services Product and Services
Table 38. Laboratory Corporation of America Holdings Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Laboratory Corporation of America Holdings Recent Developments/Updates
Table 40. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
Table 41. Metrion Basic Information, Manufacturing Base and Competitors
Table 42. Metrion Major Business
Table 43. Metrion Cardiac Safety Assessment Services Product and Services
Table 44. Metrion Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Metrion Recent Developments/Updates
Table 46. Metrion Competitive Strengths & Weaknesses
Table 47. Clario Basic Information, Manufacturing Base and Competitors
Table 48. Clario Major Business
Table 49. Clario Cardiac Safety Assessment Services Product and Services
Table 50. Clario Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Clario Recent Developments/Updates
Table 52. Clario Competitive Strengths & Weaknesses
Table 53. Banook Group Basic Information, Manufacturing Base and Competitors
Table 54. Banook Group Major Business
Table 55. Banook Group Cardiac Safety Assessment Services Product and Services
Table 56. Banook Group Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Banook Group Recent Developments/Updates
Table 58. Banook Group Competitive Strengths & Weaknesses
Table 59. Iqvia Basic Information, Manufacturing Base and Competitors
Table 60. Iqvia Major Business
Table 61. Iqvia Cardiac Safety Assessment Services Product and Services
Table 62. Iqvia Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Iqvia Recent Developments/Updates
Table 64. Iqvia Competitive Strengths & Weaknesses
Table 65. Celerion Basic Information, Manufacturing Base and Competitors
Table 66. Celerion Major Business
Table 67. Celerion Cardiac Safety Assessment Services Product and Services
Table 68. Celerion Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Celerion Recent Developments/Updates
Table 70. Celerion Competitive Strengths & Weaknesses
Table 71. Certara Basic Information, Manufacturing Base and Competitors
Table 72. Certara Major Business
Table 73. Certara Cardiac Safety Assessment Services Product and Services
Table 74. Certara Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Certara Recent Developments/Updates
Table 76. Certara Competitive Strengths & Weaknesses
Table 77. Biotrial Basic Information, Manufacturing Base and Competitors
Table 78. Biotrial Major Business
Table 79. Biotrial Cardiac Safety Assessment Services Product and Services
Table 80. Biotrial Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Biotrial Recent Developments/Updates
Table 82. Biotrial Competitive Strengths & Weaknesses
Table 83. Medpace Basic Information, Manufacturing Base and Competitors
Table 84. Medpace Major Business
Table 85. Medpace Cardiac Safety Assessment Services Product and Services
Table 86. Medpace Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Medpace Recent Developments/Updates
Table 88. Medpace Competitive Strengths & Weaknesses
Table 89. Physiostim Basic Information, Manufacturing Base and Competitors
Table 90. Physiostim Major Business
Table 91. Physiostim Cardiac Safety Assessment Services Product and Services
Table 92. Physiostim Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Physiostim Recent Developments/Updates
Table 94. Physiostim Competitive Strengths & Weaknesses
Table 95. Richmond Pharmacology Basic Information, Manufacturing Base and Competitors
Table 96. Richmond Pharmacology Major Business
Table 97. Richmond Pharmacology Cardiac Safety Assessment Services Product and Services
Table 98. Richmond Pharmacology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Richmond Pharmacology Recent Developments/Updates
Table 100. Richmond Pharmacology Competitive Strengths & Weaknesses
Table 101. Ncardia Basic Information, Manufacturing Base and Competitors
Table 102. Ncardia Major Business
Table 103. Ncardia Cardiac Safety Assessment Services Product and Services
Table 104. Ncardia Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Ncardia Recent Developments/Updates
Table 106. Ncardia Competitive Strengths & Weaknesses
Table 107. Pharmaceutical Product Development Llc. Basic Information, Manufacturing Base and Competitors
Table 108. Pharmaceutical Product Development Llc. Major Business
Table 109. Pharmaceutical Product Development Llc. Cardiac Safety Assessment Services Product and Services
Table 110. Pharmaceutical Product Development Llc. Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Pharmaceutical Product Development Llc. Recent Developments/Updates
Table 112. Pharmaceutical Product Development Llc. Competitive Strengths & Weaknesses
Table 113. Reaction Biology Basic Information, Manufacturing Base and Competitors
Table 114. Reaction Biology Major Business
Table 115. Reaction Biology Cardiac Safety Assessment Services Product and Services
Table 116. Reaction Biology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Reaction Biology Recent Developments/Updates
Table 118. Reaction Biology Competitive Strengths & Weaknesses
Table 119. Eurofins Discovery Basic Information, Manufacturing Base and Competitors
Table 120. Eurofins Discovery Major Business
Table 121. Eurofins Discovery Cardiac Safety Assessment Services Product and Services
Table 122. Eurofins Discovery Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Eurofins Discovery Recent Developments/Updates
Table 124. Eurofins Discovery Competitive Strengths & Weaknesses
Table 125. Altasciences Basic Information, Manufacturing Base and Competitors
Table 126. Altasciences Major Business
Table 127. Altasciences Cardiac Safety Assessment Services Product and Services
Table 128. Altasciences Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Altasciences Recent Developments/Updates
Table 130. Altasciences Competitive Strengths & Weaknesses
Table 131. NEXEL Basic Information, Manufacturing Base and Competitors
Table 132. NEXEL Major Business
Table 133. NEXEL Cardiac Safety Assessment Services Product and Services
Table 134. NEXEL Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. NEXEL Recent Developments/Updates
Table 136. NEXEL Competitive Strengths & Weaknesses
Table 137. charles river Basic Information, Manufacturing Base and Competitors
Table 138. charles river Major Business
Table 139. charles river Cardiac Safety Assessment Services Product and Services
Table 140. charles river Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. charles river Recent Developments/Updates
Table 142. charles river Competitive Strengths & Weaknesses
Table 143. Scottish Institute of Electrophysiology Basic Information, Manufacturing Base and Competitors
Table 144. Scottish Institute of Electrophysiology Major Business
Table 145. Scottish Institute of Electrophysiology Cardiac Safety Assessment Services Product and Services
Table 146. Scottish Institute of Electrophysiology Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Scottish Institute of Electrophysiology Recent Developments/Updates
Table 148. Scottish Institute of Electrophysiology Competitive Strengths & Weaknesses
Table 149. Ronovation Biotech Basic Information, Manufacturing Base and Competitors
Table 150. Ronovation Biotech Major Business
Table 151. Ronovation Biotech Cardiac Safety Assessment Services Product and Services
Table 152. Ronovation Biotech Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 153. Ronovation Biotech Recent Developments/Updates
Table 154. Ronovation Biotech Competitive Strengths & Weaknesses
Table 155. Elixir Clinical Research Basic Information, Manufacturing Base and Competitors
Table 156. Elixir Clinical Research Major Business
Table 157. Elixir Clinical Research Cardiac Safety Assessment Services Product and Services
Table 158. Elixir Clinical Research Cardiac Safety Assessment Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 159. Elixir Clinical Research Recent Developments/Updates
Table 160. Elixir Clinical Research Competitive Strengths & Weaknesses
Table 161. Global Key Players of Cardiac Safety Assessment Services Upstream (Raw Materials)
Table 162. Global Cardiac Safety Assessment Services Typical Customers


List of Figures
Figure 1. Cardiac Safety Assessment Services Picture
Figure 2. World Cardiac Safety Assessment Services Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Cardiac Safety Assessment Services Total Revenue (2019-2030) & (USD Million)
Figure 4. World Cardiac Safety Assessment Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Cardiac Safety Assessment Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Cardiac Safety Assessment Services Revenue (2019-2030) & (USD Million)
Figure 13. Cardiac Safety Assessment Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 16. World Cardiac Safety Assessment Services Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 18. China Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 23. India Cardiac Safety Assessment Services Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Cardiac Safety Assessment Services by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cardiac Safety Assessment Services Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cardiac Safety Assessment Services Markets in 2023
Figure 27. United States VS China: Cardiac Safety Assessment Services Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Cardiac Safety Assessment Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Cardiac Safety Assessment Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Cardiac Safety Assessment Services Market Size Market Share by Type in 2023
Figure 31. Preclinical Cardiac Safety Assessment
Figure 32. Clinical Cardiac Safety Assessment
Figure 33. World Cardiac Safety Assessment Services Market Size Market Share by Type (2019-2030)
Figure 34. World Cardiac Safety Assessment Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Cardiac Safety Assessment Services Market Size Market Share by Application in 2023
Figure 36. Commissioned Research Institute
Figure 37. Pharmaceutical Company
Figure 38. Others
Figure 39. World Cardiac Safety Assessment Services Market Size Market Share by Application (2019-2030)
Figure 40. Cardiac Safety Assessment Services Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Laboratory Corporation of America Holdings
Metrion
Clario
Banook Group
Iqvia
Celerion
Certara
Biotrial
Medpace
Physiostim
Richmond Pharmacology
Ncardia
Pharmaceutical Product Development Llc.
Reaction Biology
Eurofins Discovery
Altasciences
NEXEL
charles river
Scottish Institute of Electrophysiology
Ronovation Biotech
Elixir Clinical Research
jiaGou

Add To Cart

gouMai

Buy Now